Sanofi's Lemtrada Helps Multiple Sclerosis Patients in Study - Bloomberg

[INCIID News Feed]

Centre Daily Times
<img alt="" height="1" width="1" />
Sanofi&#39;s Lemtrada Helps Multiple Sclerosis Patients in Study
Bloomberg
Sanofi, France&#39;s largest drugmaker, said an experimental multiple sclerosis drug acquired through the purchase of Genzyme Corp. helped patients more than Merck KGaA (MRK)&#39;s older medicine Rebif in a ...
Sanofi: MS drug Lemtrada has positive trial resultMarketWatch
Sanofi says MS drug results positiveReuters
Sanofi, Genzyme release CARE-MS I Phase 3 trial resultsPharmaceutical Business Review

all 26 news articles &raquo;


More...